NCT05617820 — Dyspareunia trial site landscape

Public-registry site landscape for NCT05617820, a Dyspareunia study sponsored by Teva Pharmaceuticals USA. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT05617820 (registry record)
Sponsor	Teva Pharmaceuticals USA
Condition(s)	Dyspareunia
Phase	PHASE3
Listed sites	48
Site countries	United States, El Salvador, Honduras

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT05617820 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.